vs
Cytek Biosciences, Inc.（CTKB）与Seer, Inc.（SEER）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是Seer, Inc.的14.8倍（$62.1M vs $4.2M）。Cytek Biosciences, Inc.净利率更高（-70.9% vs -380.7%，领先309.8%）。Cytek Biosciences, Inc.同比增速更快（8.1% vs 5.0%）。Cytek Biosciences, Inc.自由现金流更多（$-1.8M vs $-11.1M）。过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 17.1%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
Seer, Inc.是一家总部位于美国加利福尼亚州雷德伍德城的生物技术企业，成立于2017年，专注于开发蛋白质组学研究领域的相关技术，目前在生物科研技术开发领域开展业务。
CTKB vs SEER — 直观对比
营收规模更大
CTKB
是对方的14.8倍
$4.2M
营收增速更快
CTKB
高出3.1%
5.0%
净利率更高
CTKB
高出309.8%
-380.7%
自由现金流更多
CTKB
多$9.3M
$-11.1M
两年增速更快
CTKB
近两年复合增速
17.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $4.2M |
| 净利润 | $-44.1M | $-16.0M |
| 毛利率 | 52.9% | 52.0% |
| 营业利润率 | -9.0% | -413.8% |
| 净利率 | -70.9% | -380.7% |
| 营收同比 | 8.1% | 5.0% |
| 净利润同比 | -557.1% | 26.4% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBSEER
| Q4 25 | $62.1M | $4.2M | ||
| Q3 25 | $52.3M | $4.1M | ||
| Q2 25 | $45.6M | $4.1M | ||
| Q1 25 | $41.5M | $4.2M | ||
| Q4 24 | $57.5M | $4.0M | ||
| Q3 24 | $51.5M | $4.0M | ||
| Q2 24 | $46.6M | $3.1M | ||
| Q1 24 | $44.9M | $3.1M |
净利润CTKBSEER
| Q4 25 | $-44.1M | $-16.0M | ||
| Q3 25 | $-5.5M | $-18.2M | ||
| Q2 25 | $-5.6M | $-19.4M | ||
| Q1 25 | $-11.4M | $-19.9M | ||
| Q4 24 | $9.6M | $-21.7M | ||
| Q3 24 | $941.0K | $-21.3M | ||
| Q2 24 | $-10.4M | $-22.9M | ||
| Q1 24 | $-6.2M | $-20.7M |
毛利率CTKBSEER
| Q4 25 | 52.9% | 52.0% | ||
| Q3 25 | 52.7% | 51.2% | ||
| Q2 25 | 52.3% | 52.1% | ||
| Q1 25 | 48.6% | 49.0% | ||
| Q4 24 | 58.5% | 50.6% | ||
| Q3 24 | 56.3% | 48.1% | ||
| Q2 24 | 54.6% | 56.3% | ||
| Q1 24 | 51.3% | 44.4% |
营业利润率CTKBSEER
| Q4 25 | -9.0% | -413.8% | ||
| Q3 25 | -17.6% | -469.4% | ||
| Q2 25 | -23.3% | -506.8% | ||
| Q1 25 | -36.1% | -493.0% | ||
| Q4 24 | 5.2% | -587.2% | ||
| Q3 24 | -8.2% | -603.3% | ||
| Q2 24 | -18.3% | -882.0% | ||
| Q1 24 | -23.9% | -821.7% |
净利率CTKBSEER
| Q4 25 | -70.9% | -380.7% | ||
| Q3 25 | -10.5% | -442.5% | ||
| Q2 25 | -12.2% | -479.5% | ||
| Q1 25 | -27.5% | -474.4% | ||
| Q4 24 | 16.8% | -543.6% | ||
| Q3 24 | 1.8% | -529.0% | ||
| Q2 24 | -22.4% | -743.8% | ||
| Q1 24 | -13.8% | -674.5% |
每股收益（稀释后）CTKBSEER
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $-0.35 | ||
| Q1 24 | — | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $47.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $259.3M |
| 总资产 | $461.5M | $296.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBSEER
| Q4 25 | $90.9M | $47.3M | ||
| Q3 25 | $93.3M | $45.0M | ||
| Q2 25 | $75.5M | $37.9M | ||
| Q1 25 | $95.3M | $52.4M | ||
| Q4 24 | $98.7M | $40.8M | ||
| Q3 24 | $162.3M | $37.6M | ||
| Q2 24 | $177.9M | $31.9M | ||
| Q1 24 | $168.8M | $54.4M |
股东权益CTKBSEER
| Q4 25 | $341.7M | $259.3M | ||
| Q3 25 | $378.6M | $271.8M | ||
| Q2 25 | $377.6M | $288.3M | ||
| Q1 25 | $379.6M | $311.0M | ||
| Q4 24 | $395.7M | $327.6M | ||
| Q3 24 | $385.5M | $344.7M | ||
| Q2 24 | $389.1M | $364.7M | ||
| Q1 24 | $392.6M | $383.6M |
总资产CTKBSEER
| Q4 25 | $461.5M | $296.1M | ||
| Q3 25 | $494.9M | $308.6M | ||
| Q2 25 | $493.3M | $322.5M | ||
| Q1 25 | $482.6M | $347.3M | ||
| Q4 24 | $499.5M | $366.6M | ||
| Q3 24 | $491.2M | $383.4M | ||
| Q2 24 | $483.7M | $406.6M | ||
| Q1 24 | $492.1M | $422.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $-10.8M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-11.1M |
| 自由现金流率自由现金流/营收 | -2.9% | -264.2% |
| 资本支出强度资本支出/营收 | 1.6% | 7.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $-46.2M |
8季度趋势，按日历期对齐
经营现金流CTKBSEER
| Q4 25 | $-771.0K | $-10.8M | ||
| Q3 25 | $-3.9M | $-7.6M | ||
| Q2 25 | $108.0K | $-14.7M | ||
| Q1 25 | $-125.0K | $-11.4M | ||
| Q4 24 | $2.0M | $-11.5M | ||
| Q3 24 | $13.2M | $-14.1M | ||
| Q2 24 | $6.2M | $-10.1M | ||
| Q1 24 | $4.0M | $-10.5M |
自由现金流CTKBSEER
| Q4 25 | $-1.8M | $-11.1M | ||
| Q3 25 | $-4.6M | $-7.8M | ||
| Q2 25 | $-1.5M | $-15.2M | ||
| Q1 25 | $-974.0K | $-12.1M | ||
| Q4 24 | $1.1M | $-12.0M | ||
| Q3 24 | $12.2M | $-16.3M | ||
| Q2 24 | $5.2M | $-11.2M | ||
| Q1 24 | $3.4M | $-11.2M |
自由现金流率CTKBSEER
| Q4 25 | -2.9% | -264.2% | ||
| Q3 25 | -8.7% | -190.5% | ||
| Q2 25 | -3.2% | -375.9% | ||
| Q1 25 | -2.3% | -287.1% | ||
| Q4 24 | 1.9% | -299.8% | ||
| Q3 24 | 23.7% | -404.7% | ||
| Q2 24 | 11.0% | -366.0% | ||
| Q1 24 | 7.6% | -365.6% |
资本支出强度CTKBSEER
| Q4 25 | 1.6% | 7.0% | ||
| Q3 25 | 1.3% | 6.9% | ||
| Q2 25 | 3.5% | 14.0% | ||
| Q1 25 | 2.0% | 15.6% | ||
| Q4 24 | 1.6% | 13.4% | ||
| Q3 24 | 2.0% | 54.4% | ||
| Q2 24 | 2.3% | 38.2% | ||
| Q1 24 | 1.3% | 24.6% |
现金转化率CTKBSEER
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SEER
暂无分部数据
